全球研究抗體和試劑市場規模、佔有率、成長分析，依技術（蛋白質印跡、流式細胞儀）、依應用（蛋白質組學、藥物開發和基因組學）- 2024-2031 年產業預測

Global Research Antibodies and Reagents Market Size, Share, Growth Analysis, By Technology(western blotting, flow cytometry), By Application(proteomics, drug development and Genomics) - Industry Forecast 2024-2031

出版日期: 2024年04月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022 年全球研究抗體和試劑市場規模為 119 億美元，預計將從 2023 年的 127 億美元成長到 2031 年的 213.3 億美元，預測期內（2024-2031 年）複合年成長率為 6.70%。

研究試劑和抗體用於鑑定針對抗原的未綴合一抗。這些產品可用於定位、定量和純化蛋白質或生物分子，用於免疫組織化學、蛋白質印跡、流式細胞儀和 ELISA 等各種過程。推動研究抗體和試劑市場成長的主要原因之一是對高品質抗體的需求不斷增加，以實現研究的可重複性。由於蛋白質組學和基因組學研究的發展以及加強診斷和治療全過程的研發工作的增加，研究抗體和試劑的市場正在擴大。研究抗體和試劑市場受到神經生物學和幹細胞研究學科不斷擴大以及工業界和學術界之間合作不斷加強的影響。

此外，研究抗體和試劑市場受益於更多的政府援助、對生物標記開發的日益重視、營利性和非營利組織對研究計劃的資助增加以及對外包的興趣日益濃厚。研究抗體和試劑市場參與者也可以從對新市場、定製藥物和蛋白質療法不斷成長的需求中受益。另一方面，由於抗體製造過程的高成本和持續時間以及主要參與者的定價壓力，預計研究抗體和試劑市場的擴張將受到限制。在整個預測期內，由於品質問題日益嚴重和缺乏可重複的結果，研究抗體和試劑市場預計將遇到困難。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2023 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率 (%), 2023

主要公司簡介

Thermo Fisher Scientific, Inc.
Abcam plc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Santa Cruz Biotechnology, Inc.
GE Healthcare Life Sciences
BD Biosciences
BioLegend, Inc.
R&D Systems, Inc.
Sigma-Aldrich Corporation
Lonza Group Ltd.
Promega Corporation
Qiagen NV
Affymetrix, Inc.
Novus Biologicals, LLC
Enzo Life Sciences, Inc.
OriGene Technologies, Inc.

簡介目錄

Product Code: SQMIG35H2053

Global Research Antibodies and Reagents Market size was valued at USD 11.90 billion in 2022 and is poised to grow from USD 12.70 billion in 2023 to USD 21.33 billion by 2031, at a CAGR of 6.70% during the forecast period (2024-2031).

Research reagents and antibodies are used to identify an unconjugated primary antibody that targets antigen. These products can be used to locate, quantify, and purify proteins or biomolecules for use in various processes such as immunohistochemistry, western blotting, flow cytometry, and ELISA. One of the main reasons driving the growth of the research antibodies and reagents market is the increasing need for high-quality antibodies for research repeatability. The market for research antibodies and reagents is expanding due to the growth of proteomics and genomics research as well as an increase in R&D efforts to enhance the whole course of diagnosis and treatment. The market for research antibodies and reagents is impacted by the expanding disciplines of neurobiology and stem cell research, as well as the increased cooperation between industry and academia.

In addition, the market for research antibodies and reagents benefits from greater government assistance, increased emphasis on biomarker development, increased funding for research initiatives by for-profit and non-profit organizations, and growing interest in outsourcing. Research antibodies and reagents market participants can also benefit from the expanding need for new markets, customized medicine, and protein therapies. On the other hand, it is anticipated that the market for research antibodies and reagents will be restrained in its expansion due to the high cost and duration of the antibody creation processes, as well as pricing pressure from major players. Throughout the forecast period, the market for research antibodies and reagents is anticipated to encounter difficulties due to growing quality concerns and a dearth of repeatable results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Research Antibodies and Reagents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Research Antibodies and Reagents Market Segmental Analysis

The research antibodies and reagents market is segmented based on the technology, application and region. Based on technology, research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Based on application, the Research Antibodies and Reagents Market is segmented into proteomics, drug development and Genomics. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Research Antibodies and Reagents Market

Collaboration between academic institutions and corporate R&D departments is essential for research and innovation. These collaborations ensure that technology and information flow from the commercial sector to academia and vice versa. The growing economic instability and the accelerating speed of technology advancement have led to a significant rise in the number of these kinds of partnerships. Because research-specific antibodies and reagents have so many applications, industry players are focusing on collaborating with academic institutions to raise researcher and student understanding of emerging analytical technologies.

Restraints in the Global Research Antibodies and Reagents Market

Variations in antibody quality are a major cause of the reproducibility challenge, which is the growing realization that many study results in biomedical research cannot be repeated and that conclusions based on them may be unfounded. Variations in antibody production techniques lead to non-reproducible results. There are no universally accepted criteria of repeatability for all antibody offerings, nor validation requirements for them.

Market Trends of the Global Research Antibodies and Reagents Market

By personalized medicine, many diseases are now identified, categorized, and treated differently. This has made personalized medicine a major area of research for the healthcare industry. These advances are especially apparent in oncology. Furthermore, biopharmaceutical companies have nearly quadrupled their research and development (R&D) spending in customized medicine over the last five years; over the next five, this investment is expected to increase by 33%. More than ever, as personalized medicine gets traction and aids in the definition of particular patient treatments, rapid, highly sensitive, and quantitative ways to analyze proteins and related post-translational modifications in clinical specimens are needed. Additionally, researchers are focusing on discovering and comprehending various proteins because gene variants may predict a patient's propensity to respond to a particular medication. Alterations, genetic variants, and the relationships they have with different diseases.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Research Antibodies and Reagents Market by Technology

Market Overview
western blotting
flow cytometry
ELISA
Immunohistochemistry
Immunofluorescence
Immunoprecipitation
and other technologies

Global Research Antibodies and Reagents Market by Application

Market Overview
proteomics
drug development and Genomics

Global Research Antibodies and Reagents Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Santa Cruz Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R&D Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novus Biologicals, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Life Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments